Meeting Announcement: June 26, 2013 General and Plastic Surgery Devices Panel of the Medical Devices Meeting AnnouncementMay 23, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments
On June 26, 2013, the committee will discuss and make recommendations regarding the possible reclassification of blood lancet devices. The committee will discuss whether new scientific data are sufficient to support the reasonable assurance of safety and effectiveness to develop special controls that support regulation of blood lancets from class I to class II and class III.
WASHINGTON--(BUSINESS WIRE)--May 21, 2013--The Association of Clinical Research Organizations announced today it has joined the Coalition of Small Business Innovators (CSBI). CSBI is a national, non-partisan coalition of organizations dedicated to stimulating sustained, private investment in...
WASHINGTON--(BUSINESS WIRE)--May 21, 2013--The Biotechnology Industry Organization (BIO) announced today it has joined the Coalition of Small Business Innovators (CSBI). CSBI is a national, non-partisan coalition of organizations dedicated to stimulating sustained, private investment in small,...
Coalition of Small Business Innovators Launches to Encourage a Tax Code that Creates Jobs and Promotes Long-Term Economic GrowthMay 21, 2013 10:00 am | by The Associated Press | News | Comments
WASHINGTON--(BUSINESS WIRE)--May 21, 2013--The Coalition of Small Business Innovators (CSBI) launches today with 15 organizations representing thousands of pre-revenue small businesses that employ millions of Americans in all 50 states. The Coalition aims to promote small business advancement as...
It has come to our attention that you are currently marketing the uChek Urine analyzer, which is intended for use with Siemens Multistix SG10, Siemens Multistix SG, Siemens Uristix, Bayer Diastix, and Bayer Keto-Diastix reagent strips for the qualitative and semi-quantitative determination of urine analytes including glucose, urobilinogen, pH, ketone, blood, protein, bilirubin, nitrite, leukocyte, and specific gravity.
Next July, certain medical electronics will fall under the scope of RoHS—the European Union’s Restriction on Hazardous Substances. In terms of the electronics industry, that is now a tight deadline for manufacturers. Medical devices that have so far been exempt from RoHS fall into scope under the RoHS Recast (RoHS 2) beginning in July 2014.
Center for Devices and Radiological Health Appeals Processes: Questions and Answers About 517A - Draft Guidance for Industry and Food and Drug Administration StaffMay 16, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments
This draft guidance document provides CDRH proposed interpretation of key provisions of Section 517A of the Food, Drug and Cosmetic Act (FD&C Act), which was added by section 603 of the FDA Safety and Innovation Act (FDASIA) of 2012, as those provisions..
Center for Devices and Radiological Health Appeals Processes - Guidance for Industry and Food and Drug Administration StaffMay 16, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments
This guidance document describes the processes available to outside stakeholders to request additional review of decisions or actions by CDRH employees. This guidance supersedes “Medical Device Appeals and Complaints: Guidance for Dispute Resolution,” and “Resolving Scientific Disputes Concerning The Regulation of Medical Devices, A Guide to Use of the Medical Devices Dispute Resolution Panel; Final Guidance for Industry and FDA."
It’s no secret that getting a medical device to market can be a lengthy, frustrating process. Facing the new medical device excise tax and lack of clarity from the FDA around regulatory policies, medtech startups are now starting to rethink launching in the U.S.
PatientsLikeMe and CISCRP Team up with Sanofi to Spotlight Medical Heroes and Clinical Trial ParticipationMay 13, 2013 10:00 am | by The Associated Press | News | Comments
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 13, 2013--PatientsLikeMe and the nonprofit Center for Information and Study on Clinical Research Participation (CISCRP) announce a new partnership with global healthcare leader Sanofi (NYSE: SNY) to raise awareness about the benefits of participating in...
On July 18, 2013, the committee will discuss and make recommendations on the proposed regulatory classification for dental devices known as Endosseous Dental Implants (Blade-form), one of the remaining preamendments Class III devices. The Class III blade-form endosseous dental implant is a device placed into the maxilla or mandible and composed of biocompatible material with sufficient strength to support a dental restoration.
Gain best practices in overcoming international labeling challenges at the Medical Device Global Labeling Strategies Conference, July 24-25, 2013 in Minneapolis, MN. This premier marcus evans event will bring together leading medical device labeling professionals to discuss how to successfully create a label on both a national and international scale.
Meeting Announcement: June 13, 2013 Microbiology Devices Panel of the Medical Devices Advisory CommitteeMay 8, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments
The committee's discussion will involve making recommendations regarding regulatory classification to either confirm class I or reclassify these devices into class II with special controls. The committee will address issues such as device performance and public health impact to determine whether special controls are needed to ensure the safety and effectiveness of these tests through their total product life cycle.
Critics of the new 2.3% medical device excise tax are hitting new heights with their claims of dire consequences. Conservative blogger and attorney Johnathan Emord blogged that the tax will "wipe out an entire industry," and further asserts that the tax is "one of the most draconian tax burdens in history." What are the facts? Is the industry overreacting?
Meeting Announcement: June 27, 2013 Gastroenterology and Urology Devices Panel of the Medical Devices Advisory CommitteeMay 3, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments
On June 27, 2013, during session I, the committee will discuss and make recommendations regarding the proposed classification of sorbent hemoperfusion systems, one of the remaining preamendments class III devices. The class III sorbent hemoperfusion system is a device intended for the treatment of poisoning, drug overdose, hepatic coma, and metabolic disturbances.
Obesity is a major public health concern in the United States and has been linked to many health problems such as heart disease, stroke, diabetes, high blood pressure, sleep disorders, and breathing problems. Obesity (an excessive amount of body fat)...
The American Association for Cancer Research (AACR) formally issued letters to all members of the House of Representatives and the Senate urging them to oppose recently introduced legislation that would exempt many cigars from regulation. The FDA currently regulates cigarettes, smokeless tobacco and roll-your-own cigarette tobacco, and...
510(k) Device Modifications: Deciding When to Submit a 510(k) for a Change to an Existing Device, May 17, 2013April 25, 2013 12:00 am | by U.S. Food & Drug Administration | News | Comments
The purpose of the meeting is to discuss FDA’s past, present, and future policy on 510(k) Modifications with external stakeholders. FDA seeks comment from stakeholders on different options, both in the form of submissions to the docket for the Federal Register notice associated with this meeting and in discussion during the public meeting.
The FDA laid out plans to revamp its postmarket surveillance of medical devices, and a large part of that has to do with finalizing and implementing a long-awaited Unique Device Identifier program to better track and monitor devices. The federal watchdog agency aims this year to finalize a UDI rule...
It's unlikely that his waning days as chairman of the Senate Finance Committee will see Sen. Max Baucus (D-Mont.) having a "Come-to-Jesus" moment on the medical device tax, but his retirement does change the game on repealing the levy.
Colorado-based medical device maker Spectranetics (NSDQ:SPNC) broke out the red ink in 2013, blaming the swing partly on the newly implemented medtech excise tax, which requires that companies pay a 2.3% levy on all U.S. sales of applicable medical devices.
Sen. Max Baucus (D-Mont.) is reportedly planning to retire when his current term ends this year, according to multiple news outlets today, potentially removing a key opponent to the medical device industry's push to repeal a 2.3% tax on U.S. medtech sales.
MedWatcher is a mobile application (app) that allows individuals to submit voluntary reports of serious medical device problems to the FDA using a smart phone or tablet. The app makes it easier and faster for healthcare professionals, patients and caregivers to send voluntary reports of medical device problems to the FDA, compared to the traditional reporting methods.
When my mother tells me that her computer is running slow and she needs me to “clean it up” for her, I never imagined the day she might be calling about the same problem with a medical device. While I’d obviously not have the same access to it that I have on a computer, it does reflect a scary situation in medical device technology today.
House Representatives Erik Paulsen (R-Minn.) and Ron Kind (D-Wisc.) are looking for immediate action on the medical device tax. The House of Representatives' lead medtech tax repeal bill co-sponsors urged immediate action to strike what they called an "onerous policy that is harming the great American success story."